Research
Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies
BMJ 2017; 357 doi: https://doi.org/10.1136/bmj.j1550 (Published 26 April 2017) Cite this as: BMJ 2017;357:j1550
Data supplement
Web Extra
- Data Supplement - Appendix 1: Searches
- Data Supplement - Appendix 2: Supplementary tables A and B
- Data Supplement - Appendix 3: Quality score
Web Extra
- Data Supplement - Appendix 1: Searches
- Data Supplement - Appendix 2: Supplementary tables A and B
- Data Supplement - Appendix 3: Quality score
Related articles
- Editorial Published: 26 April 2017; BMJ 357 doi:10.1136/bmj.j1947
- Practice Published: 09 March 2020; BMJ 368 doi:10.1136/bmj.m710
- Research Published: 31 March 2020; BMJ 368 doi:10.1136/bmj.m772
- Clinical Review Published: 19 May 2021; BMJ 373 doi:10.1136/bmj.n784
See more
- Specialty training: record number of applicants and posts filled in England, say officialsBMJ July 04, 2022, 378 o1649; DOI: https://doi.org/10.1136/bmj.o1649
- Covid-19: Pandemic sickness pay rules for NHS staff to come to an endBMJ July 04, 2022, 378 o1648; DOI: https://doi.org/10.1136/bmj.o1648
- Effect of crisis in NHS dentistry on dental trainingBMJ July 04, 2022, 378 o1580; DOI: https://doi.org/10.1136/bmj.o1580
- Roe v Wade: Medical bodies declare support for abortion rights, as doctors and states face confusionBMJ July 04, 2022, 378 o1643; DOI: https://doi.org/10.1136/bmj.o1643
- US Supreme Court restricts environment agency’s power to regulate carbon emissionsBMJ July 04, 2022, 378 o1642; DOI: https://doi.org/10.1136/bmj.o1642
Cited by...
- Guidelines for the use of buprenorphine for opioid use disorder in the perioperative setting
- Buprenorphine management in the perioperative period: educational review and recommendations from a multisociety expert panel
- Editors Comments
- A cross-sectional survey on buprenorphine-naloxone practice and attitudes in 22 Canadian emergency physician groups: a cross-sectional survey
- Trends in drug poisoning deaths, by sex, in Ireland: a repeated cross-sectional study from 2004 to 2017
- Treatment of opioid use disorder in primary care
- Opioid maintenance treatment in the Czech Republic, Norway and Denmark: a study protocol of a comparative registry linkage study
- Death after emergency department visits for opioid overdose in British Columbia: a retrospective cohort analysis
- Evidence-Based Treatment of Young Adults With Substance Use Disorders
- Principles of Care for Young Adults With Substance Use Disorders
- Scoping review protocol: the use of telemedicine in providing opioid agonist treatment and related psychosocial supports
- Medication Improves Age Disparities in Six-Month Treatment Retention for Opioid Use Disorder
- The Concurrent Initiation of Medications Is Associated with Discontinuation of Buprenorphine Treatment for Opioid Use Disorder
- Financing Buprenorphine Treatment in Primary Care: A Microsimulation Model
- Rise and Regional Disparities in Buprenorphine Utilization in the United States
- Lignes directrices de pratique clinique pour les personnes sans-abri, logees precairement, ou ayant connu litinerance
- Comparative effectiveness of buprenorphine-naloxone versus methadone for treatment of opioid use disorder: a population-based observational study protocol in British Columbia, Canada
- Toxicology and prescribed medication histories among people experiencing fatal illicit drug overdose in British Columbia, Canada
- Opioid agonist treatment and risk of mortality during opioid overdose public health emergency: population based retrospective cohort study
- Clinical guideline for homeless and vulnerably housed people, and people with lived homelessness experience
- Management of dependent use of illicit opioids
- Opioid agonist therapy during residential treatment of opioid use disorder: Cohort study on access and outcomes
- Injectable opioid agonist treatment for opioid use disorder: a national clinical guideline
- Canadas hidden opioid crisis: the health care systems inability to manage high-dose opioid patients: Fallout from the 2017 Canadian opioid guidelines
- La crise cachee des opioides au Canada : lincapacite du systeme de sante de gerer les patients prenant de fortes doses dopioides: Repercussions des recommandations canadiennes de 2017 sur les opioides
- Supporting Physicians and Practice Teams in Efforts to Address the Opioid Epidemic
- Quality of primary care among individuals receiving treatment for opioid use disorder
- Patient-centred care in opioid agonist treatment could improve outcomes
- Slow release oral morphine versus methadone for the treatment of opioid use disorder
- Youth and the Opioid Epidemic
- Are New Residency Graduates Prepared to Treat Opioid Use Disorder?
- Using routinely collected data to understand and predict adverse outcomes in opioid agonist treatment: Protocol for the Opioid Agonist Treatment Safety (OATS) Study
- Improving wait time from referral to opiate replacement therapy in a drug recovery service
- The 2017 Canadian opioid guideline: already time for an overhaul
- Narrowing the treatment gap in managing opioid use disorder
- Management of opioid use disorders: a national clinical practice guideline
- Suboxone: Rationale, Science, Misconceptions
- Availability of naloxone in Canadian pharmacies:a population-based survey
- Opioid agonist therapy
- Opioid substitution treatment is linked to reduced risk of death in opioid use disorder